3 results
To compare the effect of paclitaxel plus MORAb-003 to paclitaxel plus placebo on progression free survival (PFS) as determined by RECIST in subjects who are in a first platinum-resistant or refractory relapse of ovarian cancer.
Primary Objective: To predict the efficacy of an implanted VNS system from the effects of tVNS.Secondary Objective(s): To assess the effects of tVNS and VNS treatment. A broad set of parameters, including EEG parameters, cortical excitability and…
Primary Objective:• To assess and compare efficacy of sacituzumab govitecan to TPC as measured by progression free survival (PFS) as determined by blinded independent central review (BICR) using Response Evaluation Criteria in Solid Tumors Version 1…